APOLLO Trial Transcatheter Mitral Valve Replacement with the Medtronic Intrepid TMVR System in patients with severe symptomatic mitral regurgitation.
APOLLO Trial for patients with Mitral regurgitation
Sponsor: Medtronic, Inc.
Enrolling: Male and Female Patients
IRB Number: AAAR5579
U.S. Govt. ID: NCT03242642
Contact: Kate Dalton: 347-514-3366 / keb2114@cumc.columbia.edu
Additional Study Information: This is designed for patients with severe, symptomatic mitral regurgitation who are not candidates for conventional mitral repair.
Susheel Kodali, MD
Do You Qualify?
Do you have mitral regurgitation? Yes No
Do you have heart palpitations? Yes No
Do you have shortness of breath? Yes No
You may be eligible for this study

Place Holder

For more information, please contact:
Kate Dalton